BioNTech SE (BNTX) Cash from Operations Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) Cash from Operations Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.87% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -28.96% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.58% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -119.28% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 100.14% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 151.70% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 56.79% |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 172.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 172.77% |
| Sep 30, 2025 | 230.08% |
| Jun 30, 2025 | -90.54% |
| Mar 31, 2025 | -138.24% |
| Dec 31, 2024 | -154.08% |
| Sep 30, 2024 | -179.46% |
| Jun 30, 2024 | -63.32% |
| Mar 31, 2024 | 52.59% |
| Dec 31, 2023 | 8.22% |
| Sep 30, 2023 | -81.67% |
| Jun 30, 2023 | 14.23% |
| Mar 31, 2023 | -115.99% |
| Dec 31, 2022 | 270.69% |
| Sep 30, 2022 | 172.25% |
| Jun 30, 2022 | 3,362.17% |
| Mar 31, 2022 | 1,210,566,204.64% |
| Dec 31, 2021 | 76,811,712.31% |
| Sep 30, 2021 | 687.12% |
| Jun 30, 2021 | 607.50% |
| Mar 31, 2021 | -100.00% |